Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 47 | 0 | 4 | 0 | €685.20 | €753.63 | 9.987% |
| Biogen Inc. | 44 | 1 | 4 | 0 | €195.30 | €294.45 | 50.767% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | €371.40 | €382.71 | 3.044% |
| Regeneron Pharmaceuticals Inc. | 33 | 1 | 6 | 1 | €825.20 | €957.22 | 15.999% |
| Merck & Co. Inc. | 28 | 1 | 4 | 0 | €122.60 | €124.93 | 1.900% |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €61.50 | €85.64 | 39.258% |
| Intra-Cellular Therapies Inc. | 23 | 0 | 8 | 0 | €69.00 | €79.43 | 15.115% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €127.05 | €137.63 | 8.331% |
| Amgen Inc. | 22 | 0 | 3 | 0 | €252.35 | €294.28 | 16.617% |
| BioMarin Pharmaceutical Inc. | 21 | 0 | 3 | 0 | €75.64 | €102.62 | 35.668% |
| Zoetis Inc. A | 20 | 1 | 3 | 1 | €148.06 | €201.64 | 36.185% |
| Sutro Biopharma Inc | 18 | 0 | 4 | 0 | €3.16 | €11.05 | 249.633% |
| Natural Alternat. | 18 | 1 | 1 | 0 | €6.30 | - | - |
| AbbVie Inc. | 18 | 1 | 1 | 1 | €149.26 | €175.79 | 17.773% |
| Abbott Laboratories | 16 | 0 | 4 | 0 | €100.48 | €116.81 | 16.250% |
| Krystal Biotech | 16 | 0 | 3 | 0 | €145.15 | €173.22 | 19.338% |
| TG Therapeutics Inc. | 20 | 4 | 3 | 0 | €12.58 | €27.00 | 114.527% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €10.87 | €22.78 | 109.621% |
| United Therapeutics | 15 | 0 | 0 | 0 | €220.00 | €289.92 | 31.782% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.94 | €26.01 | 18.534% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €41.40 | €82.93 | 100.317% |
| Acorda Therapeutics Cdt | 15 | 0 | 2 | 0 | €0.47 | - | - |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €36.60 | €46.08 | 25.908% |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €10.60 | €21.39 | 101.821% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €15.63 | €28.17 | 80.216% |